0001104659-21-119384.txt : 20210924
0001104659-21-119384.hdr.sgml : 20210924
20210924172331
ACCESSION NUMBER: 0001104659-21-119384
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210831
FILED AS OF DATE: 20210924
DATE AS OF CHANGE: 20210924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Litchman Manuel MD
CENTRAL INDEX KEY: 0001709485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38191
FILM NUMBER: 211278315
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSTANG BIO, INC.
CENTRAL INDEX KEY: 0001680048
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473828760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 7816524507
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm2128458-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-31
0
0001680048
MUSTANG BIO, INC.
MBIO
0001709485
Litchman Manuel MD
377 PLANTATION STREET
WORCESTER
MA
01605
1
1
0
0
President and CEO
COMMON STOCK
2021-08-31
4
A
0
2746
2.58
A
962987
D
These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period).
Includes restricted stock units, which vest over various time periods.
/s/ Manuel Litchman
2021-09-24